Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection

被引:346
作者
Milich, D
Liang, TJ
机构
[1] Vaccine Res Inst San Diego, San Diego, CA 92109 USA
[2] NIDDK, Liver Dis Sect, NIH, Bethesda, MD USA
基金
美国国家卫生研究院;
关键词
D O I
10.1053/jhep.2003.50453
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The function of the hepatitis B e antigen (HBeAg) is largely unknown because it is not required for viral assembly, replication, or infection. In this report we chronicle clinical and experimental studies in an attempt to understand the role of HBeAg in natural infection. These studies largely have focused on clinical-pathologic features of HBeAg-negative variants in acute and chronic HBV infection, mutational analysis in animal models of hepadnavirus infection, and the use of transgenic murine models. The clinical and experimental data suggest that serum HBeAg may serve an immunoregulatory role in natural infection. To the contrary, cytosolic HBeAg serves as a target for the inflammatory immune response. These dual roles of the HBeAg and its ability to activate or tolerize T cells show the complexity of the interactions between the HBeAg and the host during HBV infection.
引用
收藏
页码:1075 / 1086
页数:12
相关论文
共 105 条
  • [1] CHRONIC ACTIVE HEPATITIS WITH HEPATITIS-B VIRUS-DNA AND ANTIBODY AGAINST E-ANTIGEN IN THE SERUM - DISTURBED SYNTHESIS AND SECRETION OF E-ANTIGEN FROM HEPATOCYTES DUE TO A POINT MUTATION IN THE PRECORE REGION
    AKAHANE, Y
    YAMANAKA, T
    SUZUKI, H
    SUGAI, Y
    TSUDA, F
    YOTSUMOTO, S
    OMI, S
    OKAMOTO, H
    MIYAKAWA, Y
    MAYUMI, M
    [J]. GASTROENTEROLOGY, 1990, 99 (04) : 1113 - 1119
  • [2] AKARCA US, 1994, HEPATOLOGY, V19, P1366
  • [3] INTERFERON THERAPY FOR THE ANTI-HBE POSITIVE FORM OF CHRONIC HEPATITIS-B
    ALBERTI, A
    FATTOVICH, G
    [J]. ANTIVIRAL RESEARCH, 1994, 24 (2-3) : 145 - 153
  • [4] ANGUS PW, 1995, HEPATOLOGY, V21, P14, DOI 10.1016/0270-9139(95)90401-8
  • [5] MATERNOFETAL TRANSMISSION OF IGG-BOUND HEPATITIS-B E-ANTIGEN
    ARAKAWA, K
    TSUDA, F
    TAKAHASHI, K
    ISE, I
    NAITO, S
    KOSUGI, E
    MIYAKAWA, Y
    MAYUMI, M
    [J]. PEDIATRIC RESEARCH, 1982, 16 (03) : 247 - 250
  • [6] VARIATIONS OF HEPATITIS-B VIRUS PRECORE/CORE GENE SEQUENCE IN ACUTE AND FULMINANT HEPATITIS-B
    AYE, TT
    UCHIDA, T
    BECKER, SO
    HIRASHIMA, M
    SHIKATA, T
    KOMINE, F
    MORIYAMA, M
    ARAKAWA, Y
    MIMA, S
    MIZOKAMI, M
    LAU, JYN
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (06) : 1281 - 1287
  • [7] SELECTION OF A PRECORE MUTANT AFTER VERTICAL TRANSMISSION OF DIFFERENT HEPATITIS-B VIRUS VARIANTS IS CORRELATED WITH FULMINANT-HEPATITIS IN INFANTS
    BAHN, A
    HILBERT, K
    MARTINE, U
    WESTEDT, J
    VONWEIZSACKER, F
    WIRTH, S
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1995, 47 (04) : 336 - 341
  • [8] Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection
    Baron, JL
    Gardiner, L
    Nishimura, S
    Shinkai, K
    Locksley, R
    Ganem, D
    [J]. IMMUNITY, 2002, 16 (04) : 583 - 594
  • [9] Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication
    Baumert, TF
    Rogers, SA
    Hasegawa, K
    Liang, TJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (10) : 2268 - 2276
  • [10] Precore mutants revisited
    Baumert, TF
    Liang, TJ
    [J]. HEPATOLOGY, 1996, 23 (01) : 184 - 186